Cuure

Based in France, Cuure specializes in personalized health and wellness supplements, aiming to enhance users' quality of life through tailored nutritional solutions. Cuure, founded in 2019 in Paris, France, focuses on offering personalized health supplements. The company has successfully completed three funding deals, with its latest being a Series A round on September 15, 2022, raising EUR 5. 946 mn led by CapAgro, along with Newfund Management, JamJar Investments, and Verlinvest.

The total amount raised by Cuure to date is EUR 5. 946 mn, and it currently has a valuation of EUR 29. 946 mn. Cuure specializes in health and wellness supplements designed to enhance the quality of life for its users.

The company's core offerings include a range of personalized nutritional supplements that address various health needs, such as boosting immunity, enhancing energy levels, and supporting overall well-being. These products are formulated based on individual health profiles, allowing for tailored solutions that cater to the unique requirements of their customers. Cuure targets a diverse client base, primarily focusing on health-conscious consumers in Western European markets, including France, Germany, and the Netherlands. The company aims to empower individuals to take control of their health through accessible and scientifically-backed supplement solutions.

Cuure generates revenue primarily through a direct-to-consumer model, offering subscription-based services that provide monthly deliveries of their personalized supplements. This transactional structure allows customers to select and adjust their product choices based on evolving health needs. Pricing plans typically reflect varying levels of product customization and quantities, ensuring that clients receive tailored solutions at competitive rates. Flagship products within their range are prominently featured as part of these subscription offerings, emphasizing their unique formulations.

The revenue model illustrates a consistent engagement with customers who are seeking long-term health improvements through regular use of Cuure's products. In September 2022, Cuure raised EUR 5. 946 mn in Series A funding led by CapAgro. The company plans to utilize this funding to scale operations and accelerate growth, particularly focusing on generating sustainable innovations in the agriculture and food sectors.

Future initiatives include the development and launch of new products, although specific release dates have not yet been disclosed. Cuure aims to expand its reach into additional markets across Europe, specifically targeting growth in Germany and the Netherlands, by the end of 2023.